Skip to main content
Clinical Trials/NCT03835403
NCT03835403CompletedNot Applicable

Public Access Defibrillation by Activated Citizen First-responders - The HeartRunner Trial

Emergency Medical Services, Capital Region, Denmark2 sites in 1 country2,114 target enrollmentStarted: May 15, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
2,114
Locations
2
Primary Endpoint
30-day survival

Study Overview

Brief Summary

The study will assess 30-day survival for cases where volunteer citizen responders ('heart runners') were activated through a smartphone app to retrieve an AED in case of suspected out-of-hospital cardiac arrest (OHCA) versus standard emergency medical services care. The study will randomize emergency medical dispatch center incoming calls which are suspected out-of-hospital cardiac arrest, such that half will be randomized to activation of heart runners and half to no activation of heart runners (standard care). The study will also assess physical or psychological risks involved for the activated heart runners.

Detailed Description

Chances of survival after out-of-hospital cardiac arrest decrease 10% per minute from collapse until defibrillation. Activating volunteer citizens through the emergency medical dispatch center can potentially increase rates of bystander defibrillation and survival. The HeartRunner trial will investigage the effect of activating registered volunteer citizens through a mobile app integrated with the emergency medical services on 30-day survival following out-of-hospital cardiac arrest. Both arms will receive standard care by the Emergency Medical Services. The intervention arm will additionally receive the activation of volunteer citizen responders. The randomization will take place independently in 3 different strata according to heart runner distance to OHCA (< 3 min, 3-9 min, > 9 min). The trial will also assess whether it is safe, both physically and psychologically, to activate volunteer citizen responders to respond to out-of-hospital cardiac arrests.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
8 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All out-of-hospital cardiac arrests recognized by Emergency Medical Dispatcher and where the HeartRunner system is activated.
  • Non-traumatic etiology, this excludes intoxication, drowning or suicide.
  • Age > 7 years

Exclusion Criteria

  • Caller is not in direct contact with the patient
  • If Emergency Medical Dispatcher deems AED is not indicated, e.g., in nursing homes where trained personal is present.
  • OHCAs not treated by the EMS due to ethical reasons or obvious signs of death
  • OHCAs with no heart runners within 1800 meters
  • Not true cardiac arrest (suspected, but not verified)
  • EMS-witnessed OHCAs
  • Emergency medical dispatchers are instructed not to activate heart runners in case any of the exclusion criteria above. However, since it can be challenging for emergency medical dispatchers to gather sufficient information about the patient within the first few minutes, heart runners will admittedly be activated even though they should not have been. Since randomization will occur for all cases in which a heart runner is activated, cases with any of the exclusion criteria will be secondarily excluded.
  • These cases will be accounted for but not included in analyses of outcome. Our pilot study showed approximately 60% of suspected cardiac arrests were true cardiac arrests. Therefore, we expect 40% of cases for which heart runners were dispatched not to be true cardiac arrests.

Arms & Interventions

Usual Care (control arm)

No Intervention

These cardiac arrests will receive standard EMS response.

HeartRunner Activation

Experimental

For these cardiac arrests, HeartRunners will be activated in addition to standard EMS response.

Intervention: Activation of HeartRunners (Other)

Outcomes

Primary Outcomes

30-day survival

Time Frame: 30 days after date of out-of-hospital cardiac arrest

Patient alive 30 days after date of out-of-hospital cardiac arrest

Secondary Outcomes

  • Rates of return of spontaneuous circulation(Immediately after out-of-hospital cardiac arrest)
  • Rates of survival after 1 year(1 year after date of out-of-hospital cardiac arrest)
  • Rates of bystander cardiopulmonary resuscitation(During cardiac arrest)
  • Rates of neurological intact survival(At hospital discharge)
  • Rates of bystander defibrillation(During cardiac arrest)

Investigators

Sponsor
Emergency Medical Services, Capital Region, Denmark
Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Fredrik Folke

MD, PhD, Head of Research

Emergency Medical Services, Capital Region, Denmark

Study Sites (2)

Loading locations...

Similar Trials